Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 653

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 653
---
 shares of Kintara
Common Stock and do not represent outstanding shares of TuHURA Common Stock, and the CVRs do not obligate TuHURA to buy back some or all of its shares. As such, the CVRs are not precluded from being classified within equity. Given the CVRs are
initially being recorded within Equity, if the CVR Milestone were to be achieved, the combined Company would issue additional Common Stock, thereby resulting in a reclass of the CVRs from Additional paid-in
capital - CVRs to Common Stock and Additional paid-in capital. As a result, the accounting for the CVR is determined to have zero net effect on total equity within the TuHURA historical consolidated balance
sheet as of December 31, 2024.

Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent
changes in fair value are not recognized if the contracts continue to be classified in equity. TuHURA estimated the valuation of the CVR arrangement. Since the Milestone is based on ten participants in the
REM-001 study and 8 weeks of follow-up, management determined that the achievement of the Milestone is probable at the time of the filing of this registration statement.
The Kintara Merger Agreement specifies achievement of the Milestone will result in the issuance of the CVR Shares. TuHURA leveraged the fair value level 1 input of the closing price of TuHURA’s Common Stock on April 21, 2025, of $4.09
multiplied by 1,539,938 shares resulting in an estimated valuation of the CVR Shares of approximately $6,298,346.

Common Stock Purchase Warrants (“Penny Warrants”) Issued for Transaction Costs Incurred

Following the consummation of the Reverse Recapitalization with
Kintara, and in connection with certain transaction costs that would have been due for underwriting and other fees due to the investment bank as a result of the closing of the merger with Kintara, the newly combined TuHURA entered into an
arrangement with the investment bank, whereby TuHURA would pay $2,000,000 immediately after the close, $500,000 within 60 days after the close, and also issue the investment bank unregistered common stock purchase warrants to purchase up to 297,029
shares of common stock of TuHURA, $0.001 par value, at an exercise price of $0.01 per share (